| Ukraine | Turquie | Espagne | |
| Élimination du cancer du foie | de $18,000 | de $10,800 | de $35,000 |
| Résection hépatique | de $12,000 | de $11,700 | de $35,000 |
| Chimioembolisation du foie | de $3,500 | de $7,500 | de $12,000 |
| Ablation par radiofréquence du foie | de $4,500 | de $3,500 | de $8,500 |
| Chimiothérapie pour le cancer du foie | - | de $1,800 | de $577 |
Bookimed ne rajoute pas de frais pour les traitements de Métastases dans le foie. Les tarifs proviennent des listes de prix officielles des cliniques. Vous payez directement à la clinique pour votre traitement à votre arrivée dans le pays.
Bookimed s'engage pour votre sécurité. Nous ne travaillons qu'avec des établissements médicaux qui respectent des normes internationales élevées dans le traitement de Métastases dans le foie et qui possèdent les licences nécessaires pour accueillir des patients internationaux dans le monde entier.
Bookimed offre une assistance experte gratuite. Un coordinateur médical personnel vous accompagne avant, pendant et après votre traitement, en résolvant tous les problèmes. Vous n'êtes jamais seul dans votre parcours de traitement de Métastases dans le foie.
Chercheur principal à l'Institut National de Chirurgie et de Transplantologie, expert en pathologie kystique du pancréas.
Le Dr Odarchenko est l'un des plus grands spécialistes du sarcome en Ukraine, avec plus de 20 ans d'expérience en chirurgie oncologique. Il combine son expertise chirurgicale avec des connaissances en radiothérapie pour une prise en charge complète des métastases hépatiques.
Medical services for liver metastasis in Ukraine remain operational in major cities like Kyiv. Safety depends on your specific location and the facility infrastructure. Specialized centers provide radiofrequency ablation and chemoembolization. International patients should prioritize clinics with independent power supplies and emergency ICU support.
Bookimed Expert Insight: Ukraine remains a high-volume hub with over 1,200 requests served recently despite conflict. Data shows specialized surgeons like Dr. Rostyslav Valikhnovskyi have performed over 15,000 operations. Large networks like Dobrobut manage 11,000 surgeries annually, suggesting high clinical stability. Choose facilities in Kyiv that have remained continuously active for the best reliability.
Patient Consensus: Patients note it is vital to confirm how centers handle power loss and air raids. Most advise bringing complete pathology reports and having a clear contingency plan for transport delays.
Top Ukrainian clinics for liver metastasis include Dobrobut Medical Network and Spizhenko Clinic. These Kyiv-based centers provide ISO-certified care. They use multidisciplinary tumor boards. Treatment often combines liver resection, radiofrequency ablation, and chemoembolization. High patient volumes and specialized hepatobiliary expertise define these institutions.
Bookimed Expert Insight: Kyiv centers like Dobrobut show a pattern of high-volume efficiency. They treat over 330,000 patients annually. This volume suggests a robust infrastructure for complex cases. Expert surgeons like Dr. Konstantin Kopchak often hold dual research roles. This bridge between research and surgery typically ensures adherence to international protocols.
Patient Consensus: Patients emphasize finding centers that combine oncology, hepatobiliary surgery, and interventional radiology. Many recommend getting a second opinion on imaging and pathology before starting treatment.
Ukraine offers diverse modalities for liver metastases including surgical resection, radiofrequency ablation, and chemoembolization. Specialized oncology centers in Kyiv integrate these with systemic therapies like targeted drugs and modern chemotherapy. These protocols align with international NCCN standards for high-precision oncological care.
Bookimed Expert Insight: Patient volume often signals surgical proficiency in complex liver cases. For instance, Dobrobut Medical Network performs over 11,000 operations annually. Expert surgeons like Dr. Sergey Odarchenko or Dr. Konstantin Kopchak focus on multidisciplinary coordination. Large networks offer better access to specialized pathology and imaging for accurate staging.
Patient Consensus: Patients note that results depend heavily on the specific surgical team's experience. Many recommend bringing existing pathology reports to speed up the treatment planning process.
Leading Ukrainian specialists for liver metastasis include Dr. Sergey Odarchenko at Spizhenko Clinic and Dr. Konstantin Kopchak at Dobrobut Medical Network. These Kyiv-based experts utilize international NCCN protocols. They specialize in complex liver resection, radiofrequency ablation, and chemoembolization to treat secondary liver tumors effectively.
Bookimed Expert Insight: Ukraine ranks 3rd globally in our network for patient requests served. This high patient volume often centers on specialists like Dr. Konstantin Kopchak. He holds a h-index of 2 and has 30 papers indexed in Scopus. This suggests a deep academic focus on complex hepatobiliary cases which is vital for metastasis.
Patient Consensus: Patients note that finding a multidisciplinary team is more important than celebrity reputation. They emphasize checking if a surgeon routinely handles metastatic cases specifically rather than just general liver surgery.
Ukrainian oncology centers determine candidacy based on liver resectability and patient fitness. Surgeons prioritize complete tumor removal while preserving 20% to 30% functional liver volume. Advanced protocols like ALPPS or two-stage hepatectomy allow therapy for patients with multiple lesions or low initial liver reserves.
Bookimed Expert Insight: Patients should focus on the multidisciplinary board structure rather than hospital size. At Dobrobut Medical Network, over 11,000 operations occur annually across 75 specialties. Such high-volume centers often employ researchers like Dr. Konstantin Kopchak. These experts specialize in complex diagnostic programs, which can identify surgical options for cases initially deemed inoperable.
Patient Consensus: Patients note that initial systemic therapy is common to shrink tumors before surgery. They emphasize that a multidisciplinary tumor board decision provides more confidence than a single surgeon's opinion.